Michael Stubblefield
Net Worth
Last updated:
What is Michael Stubblefield net worth?
The estimated net worth of Mr. Michael Stubblefield is at least $260,015,646 as of 16 Nov 2022. He owns shares worth $162,130,652 as insider, has earned $58,484,994 from insider trading and has received compensation worth at least $39,400,000 in Avantor, Inc. and Avantor, Inc..
What is the salary of Michael Stubblefield?
Mr. Michael Stubblefield salary is $3,940,000 per year as Pres, Chief Executive Officer & Director in Avantor, Inc.. He also receives $3,940,000 as Pres, Chief Executive Officer & Director in Avantor, Inc..
How old is Michael Stubblefield?
Mr. Michael Stubblefield is 52 years old, born in 1973.
What stocks does Michael Stubblefield currently own?
As insider, Mr. Michael Stubblefield owns shares in 2 companies:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Avantor, Inc. (AVTR-PA) | Pres, Chief Executive Officer & Director | 1,261,981 | $124.11 | $156,624,462 |
| Avantor, Inc. (AVTR) | Pres, Chief Executive Officer & Director | 429,500 | $12.82 | $5,506,190 |
What does Avantor, Inc. do?
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
What does Avantor, Inc. do?
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Michael Stubblefield insider trading
Avantor, Inc.
Mr. Michael Stubblefield has made 6 insider trades between 2020-2022, according to the Form 4 filled with the SEC. Most recently he purchased 15,000 units of AVTR stock worth $314,250 on 16 Nov 2022.
The largest trade he's ever made was exercising 880,601 units of AVTR stock on 4 Dec 2020. As of 16 Nov 2022 he still owns at least 429,500 units of AVTR stock.
Avantor, Inc.
Mr. Michael Stubblefield has made 6 insider trades between 2020-2021, according to the Form 4 filled with the SEC. Most recently he sold 141,300 units of AVTR-PA stock worth $5,986,881 on 20 Sep 2021.
The largest trade he's ever made was exercising 880,601 units of AVTR-PA stock on 4 Dec 2020. As of 16 Nov 2022 he still owns at least 1,261,981 units of AVTR-PA stock.
Avantor key executives
Avantor, Inc. executives and other stock owners filed with the SEC:
- Dr. Gerald Brophy Ph.D. (59) Executive Vice President of Biopharma Production
- Mr. Frederic Vanderhaegen (58) Executive Vice President of Americas & Europe
- Mr. Michael Stubblefield (52) Pres, Chief Executive Officer & Director
- Mr. Michael Wondrasch (56) Executive Vice President & Chief Information Officer
- Mr. Thomas A. Szlosek (61) Executive Vice President & Chief Financial Officer